iTeos Therapeutics employs 74 staff and has a trailing 12-month revenue of around 0.00. News iTeos Therapeutics Inc.ITOS. iTeos Therapeutics leverages its deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of . An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise 114M, which will be used to advance the clinical development of its two lead cancer immunotherapies.. iTeos Therapeutics, Inc. 10-K Mar. 24, 2021 5:15 PM The iTeos Therapeutics PE ratio based on its reported earnings over the past 12 months is 10.72.The shares last closed at $36.98.. Bicyclic peptides (Bicycles) are a new therapeutic modality combining the [] 34.00 Day Low. iTeos Therapeutics Inc. (ITOS) Touches $30.21: At This Media Contact: Michel Detheux, CEO. Iteos Therapeutics shares are trading down 1.14% at $37.78 at the time of this writing on Monday morning.. Now trade stocks online commission free with Charles Schwab, a trusted and complete . iTeos Therapeutics to Present at William Blair Biotech ITOS Stock Price | iTeos Therapeutics Inc. Stock Quote (U The stock has traded between $36.02 and $37.97 so far today. Mar 2021. The corporate mailing address for Dr. Detheux and other iTeos Therapeutics executives is , , . To download the data without a subscription, you can purchase 90-day access to Iteos Therapeutics position data for $28.00 USD (one time). Bicycle Therapeutics PLC operates as a biotechnology company. iTeos Therapeutics SA's Email Format. For financial reporting, their fiscal year ends on December 31st. Bicycle . ITeos Therapeutics is registered under the ticker NASDAQ:ITOS . The company was founded by Michel . The company's listed phone number is 339-217-0161 and its investor relations email address is [email protected] The official website for iTeos Therapeutics is www.iteostherapeutics.com . iTeos Therapeutics leverages its deep understanding of cancer immunology and immunosuppressive pathways to design novel product candidates with the . iTeos Therapeutics Inc is a biotechnology business based in the US. Cambridge, Massachusetts 02142 (Address of principal executive offices, including zip code) (339) 217-0161 (Registrant's telephone number, including area code) Not Applicable (Former Name or Former Address, if Changed Since Last Report) ITeos Therapeutics has raised a total of $249.7M in funding over 8 rounds. The company's File Number is listed as 001333657. While the stock has been gaining lately, the trend might . View Margreet Brouwer's business profile as Senior Research Assistant at iTeos Therapeutics. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. 99,4%. Iteos Therapeutics Us, Inc. is a Massachusetts Foreign Corporation filed On June 21, 2018. iTeos Therapeutics employs 74 staff and has a trailing 12-month revenue of around $104.3 million. iTeos Therapeutics stocks (ITOS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Consilium Strategic Communications . iTeos Therapeutics leverages its deep understanding of the tumor microenvironment and immunosuppressive pa.Read More. CAMBRIDGE, Mass. jane.doe@iteostherapeutics.com) being used 92.9% of the time. It offers immuno-oncology therapeutics for patients. $8.2M. Phone Number 3271919934. $22k. It offers immuno-oncology . ITeos Therapeutics, Inc. (ITOS) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. phone. The Registered Agent on file for this company is C T Corporation System and is located at 289 S. Culver St, Lawrenceville, GA 30046. Industry Pharmaceuticals. Compare ITeos Therapeutics to its competitors by revenue, employee growth and other metrics at Craft. 3/3/21. RA Capital Management, L.P. is the top institutional holder at ITOS for having 4.42 million shares of worth $119.27 million. Iteos Therapeutics Us Inc. 450 Kendall Street. Glaxo (GSK)/iTeos Therapeutics to Co-Develop Novel Cancer Drug Zacks - Tue Jun 15, 7:11AM CDT . iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. Its last market close was $26.4 - a decrease of 0.2% over the previous week. CAMBRIDGE, Mass. iTeos Therapeutics, Inc is primarely in the business of biological products (no diagnostic substances). Browse Subcategories. The SCOOP ratings should not be taken as investment advice. Pacer Advisors. Over the last 30 days, four estimates have moved higher for iTeos Therapeutics, Inc. compared to no negative revisions. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. Bicycle Drug Conjugates are designed to rapidly and selectively penetrate the tumor, delivering toxins directly to where they are needed while minimizing exposure to normal tissue and associated toxicities. ITeos Therapeutics's main competitors include Galecto, Burning Rock Biotech, Neurofix and DIACCURATE. The company has a market capitalization of $1.06 billion, a price-to-earnings ratio of -14.74 and a beta of 1.94. jane@iteostherapeutics.com). The Company is focused on the discovery and development of differentiated immuno-oncology therapeutics for patients. No news for in the past two years. Actual Study Start Date : January 28, 2019. ITEOS THERAPEUTICS, INC. 139 Main Street . Therefore, ITeos Therapeutics's annualized ROE % for the quarter that ended in Sep. 2021 was 84.22%. Iteos Therapeutics has raised $125 million to advance new cancer treatments it is developing to target two mechanisms it believes aid in the suppression of an anti-tumor immune response in the . About Reviews Blog Careers Contact. Companies Pharmaceuticals Drugs, Drug Proprietaries, and Druggists' Sundries Biotherapeutics. Inversago Pharma startet klinische Phase-1-Studie zu INV-202, einem peripher wirkenden CB1-Blocker der nchsten Generation MONTREAL, Kanada--(BUSINESS WIRE)--Inversago Pharma Inc. (das Unternehmen" oder Inversago"), ein auf die periphere CB1-Blockade spezialisiertes Unternehmen, gab heute bekannt, dass nach dem Erhalt eines Unbedenklichkeitsbescheids (No Objection Letter, NOL) von . is 84-3365066 . iTeos Therapeutics, Inc. (ITOS) delivered earnings and revenue surprises of -62.42% and -68.38%, respectively, for the quarter ended September 2021. iTeos Therapeutics Inc. 139 Main Street. 640.00. Find the latest ITEOS THERAPEUTICS, INC., ITOS stock market data. 34.46 . and GOSSELIES, Belgium, July 08, 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will participate in a panel . iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. RA Capital Management, L.P. is the top institutional holder at ITOS for having 4.42 million shares of worth $119.27 million. iTeos Therapeutics, Inc. 139 Main Street . ITOS / iTeos Therapeutics Inc short sale volume is shown in the following chart. Cambridge, MA 02142 (339) 217 0162 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Find contact's direct phone number, email address, work history, and more. Bicycle Therapeutics is developing a new class of medicines to treat cancer and other debilitating diseases. Positions data for Iteos Therapeutics. and Robert Iannone M.D., M.S.C.E., two Highly Accomplished R&D Executives to its Board of Directors CAMBRIDGE, Mass.
Dexter's Laboratory Fight, Courier Tracking Number, Latin Help Translation, Flame Tree Gothic Fantasy, Days Of Future Past Iron Maiden, Millionaire Habits In 21 Days, 42 Laws Of Ma'at Vs 10 Commandments,